PRAX
Praxis·NASDAQ
--
--(--)
--
--(--)
PRAX fundamentals
Praxis (PRAX) released its earnings on Feb 19, 2026: revenue was 0 (YoY -100.00%), missed estimates; EPS was -3.5 (YoY -19.05%), missed estimates.
Revenue / YoY
0
-100.00%
EPS / YoY
-3.5
-19.05%
Report date
Feb 19, 2026
PRAX Earnings Call Summary for Q4,2025
- Pipeline Breakthroughs: 2025 capped with 2 NDAs, positioning 2026 as execution year for $20B+ CNS portfolio.
- Financial Strength: $1.5B+ cash runway, disciplined R&D/G&A growth (51% YoY).
- Commercial Ambition: Dual launches for ulixacaltamide ($10B) and relutrigine ($5B), with vormatrigine targeting $4B.
- Strategic Focus: Simplified trial designs, rare pediatric drug designations, and FDA-aligned label strategies.
- Growth Catalysts: AAN presentations, POWER1 readout, and elsunersen NDA in 2027.
Earnings
EPS
Revenue
Revenue & Expenses
Key Indicators
Praxis (PRAX) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Praxis (PRAX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Praxis (PRAX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Praxis (PRAX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Praxis (PRAX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Praxis (PRAX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from Praxis’s earnings call?What factors drove the changes in Praxis's revenue and profit?What is the market's earnings forecast for Praxis next quarter?Did Praxis beat or miss consensus estimates last quarter?What were the key takeaways from Praxis's earnings call?What is the revenue and EPS growth rate for Praxis year over year?What guidance did Praxis's management provide for the next earnings period?What is Praxis's gross profit margin?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
